{"public_id":"cl_c429f7f81c59bfbef9a5ff8424e6702f","status":"active","superseded_by_public_id":null,"corpus_id":6743454,"text":"The unadjusted intention-to-treat relative hazard for venous thromboembolism was 2.08 overall during 6.8 years for women assigned to hormone therapy compared with placebo.","confidence":0.95,"paper":{"corpus_id":6743454,"title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).","url":"https://sah.borca.ai/papers/6743454"},"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_770539fbbbf0fd732c76963c6256db70","name":"placebo","description":"The inactive comparison assignment used during the randomized HERS trial.","types":["control intervention"],"url":"https://sah.borca.ai/concepts/co_770539fbbbf0fd732c76963c6256db70"},{"public_id":"co_a844176735303cb26ac46c9b31df0eec","name":"intention-to-treat relative hazard","description":"A comparative hazard measure based on randomized assignment, reported for study outcomes.","types":["statistical measure"],"url":"https://sah.borca.ai/concepts/co_a844176735303cb26ac46c9b31df0eec"},{"public_id":"co_ee3c85098bc112d655e8beca47efa09f","name":"venous thromboembolism","description":"A thromboembolic event outcome measured during HERS and HERS II follow-up.","types":["clinical outcome"],"url":"https://sah.borca.ai/concepts/co_ee3c85098bc112d655e8beca47efa09f"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_c429f7f81c59bfbef9a5ff8424e6702f"}